TAZAROTENE
NDC 0713-0804, tazarotene, gel, from Cosette Pharmaceuticals, Inc..
- Product NDC
- 0713-0804
- Status
- Listed
- Labeler
- Cosette Pharmaceuticals, Inc.
- Dosage form
- GEL
- Route
- TOPICAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214136
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0713-0804 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TAZAROTENE1 mg/g
Pharmacologic classes
Retinoid [EPC]; Retinoids [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0713-0804-31 | 00713080431 | 1 TUBE in 1 CARTON (0713-0804-31) / 30 g in 1 TUBE |
| 0713-0804-99 | 00713080499 | 1 TUBE in 1 CARTON (0713-0804-99) / 100 g in 1 TUBE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/94749b8e-0d00-4257-a660-6d0fc8815fcfNADAC price for package 00713080431
GET /v1/drugs/nadac/00713080431NADAC price for package 00713080499
GET /v1/drugs/nadac/00713080499
Use it
Look up 0713-0804 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0713-0804 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0713-0804. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.